Related Experiment Video

Updated: May 6, 2026

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits
07:43

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits

Published on: December 27, 2013

9.2K

Engineering Specific Human iPS Reporter Cell Lines to Generate Optogenetically Modified Photoreceptors

Elise Léger-Charnay1, Amélie Slembrouck-Brec1, Olivier Goureau2

  • 1Institut de la Vision, Sorbonne Université, INSERM UMR_S968, CNRS UMR 7210, Paris, France.

Advances in Experimental Medicine and Biology
|February 10, 2025
PubMed

Insights

This study engineered induced pluripotent stem cells (iPSCs) for cell therapy to treat blindness. The modified cells express a light-sensitive protein, enabling vision restoration independently of natural photoreceptor development.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Biotechnology

Background:

  • Photoreceptor degenerative diseases cause vision loss.
  • Current cell therapy for these diseases requires transplanted cells to mature fully, forming outer segments and integrating with retinal pigmented epithelium (RPE).
  • This maturation process is a significant hurdle for successful cell transplantation.

Purpose of the Study:

  • To develop a novel cell therapy approach for photoreceptor degenerative diseases.
  • To overcome the limitations of traditional cell therapy by conferring light sensitivity to transplanted cells.
  • To create genetically engineered induced pluripotent stem cells (iPSCs) for optogenetic vision restoration.

Main Methods:

  • Utilized CRISPR/Cas9 gene editing at the AAVS1 locus to insert the Jaws microbial opsin gene into the iPSC genome.
  • Engineered iPSCs to express Jaws, a red-light sensitive chloride pump, under a specific photoreceptor promoter.
  • Generated and validated a knock-in Jaws-EGFP iPSC line, confirming its stemness and pluripotency.

Main Results:

  • Successfully generated a stable iPSC line engineered to express the Jaws-EGFP fusion protein.
  • Validated the pluripotency and stemness of the engineered iPSCs.
  • The engineered cells are prepared for differentiation into photoreceptors for transplantation.

Conclusions:

  • Optogenetic modification of iPSC-derived photoreceptors offers a promising strategy for treating blindness.
  • This approach bypasses the need for mature outer segment formation and RPE contact for light sensitivity.
  • Further studies will assess the efficacy of these engineered cells in restoring vision in animal models.
Keywords:
CRISPR/Cas9Cell therapyGene editingInduced pluripotent stem cellsMicrobial opsinOptogeneticsPhotoreceptorsRetinal degenerative diseasesRetinal organoidsVision

More Related Videos

An Optogenetic Method to Control and Analyze Gene Expression Patterns in Cell-to-cell Interactions07:59

An Optogenetic Method to Control and Analyze Gene Expression Patterns in Cell-to-cell Interactions

Published on: March 22, 2018

7.6K
Building a Simple and Versatile Illumination System for Optogenetic Experiments06:41

Building a Simple and Versatile Illumination System for Optogenetic Experiments

Published on: January 12, 2021

3.7K

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.0K
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
11.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K